#sgen

Motley Fool: Seattle Genetics Inc (SGEN) Q2 2019 Earnings Call Transcript

Image source: The Motley Fool.

Seattle Genetics Inc (NASDAQ:SGEN) Q2 2019 Earnings Call Jul 16, 2019, 4:30 p.m. ET

Contents:

Prepared Remarks

Questions and Answers

Call Participants

Trending

Prepared Remarks:

Operator

Good day, ladies and gentlemen, and welcome to today’s Seattle Genetics Second Quarter 2019 Financial Results Conference Call. Today’s conference is being recorded. For opening…

Motley Fool: Seattle Genetics’ “Growth Is Tracking Well”

Seattle Genetics (NASDAQ:SGEN) continued its solid year-over-year increases in revenue as the biotech takes advantage of recent approvals that expanded the use of Adcetris into frontline Hodgkin lymphoma and peripheral T-cell lymphoma.

Seattle Genetics results: The raw numbers

Metric

Q1 2019

Q1 2018

Year-Over-Year Change

Revenue

$195.2 million

$140.6 million

39%

Incom…

#SGEN Earning declared EPS = -0.42 vs estimate= -0.27 for Q3/18 #sym #spy #earnings #markets

Earning released for SGEN: Actual EPS = -0.42 per share Estimate = -0.27 per share

Get our earning updates on your mobile as soon as they are released

SGEN report:

The mean EPS over the last 16 releases is -0.2 per share. The current EPS at -0.42 per share is below the average EPS per share of the last 16 quaterly earning releases.

SGEN Stock Chart:

SGEN Scores:

SGEN Fundamental…

$SGEN 2018-08-13 : Transcripts- SGEN (UMRX) Q2 2018 Earnings Conference Call Transcript Motley Fool

[s2If !current_user_can(access_s2member_level0)] Please login to read the transcript. [lwa] [/s2If][s2If current_user_can(access_s2member_level0)]

Prepared Remarks

Questions and Answers

Call Participants

Prepared Remarks:

Operator

Good day, ladies and gentlemen. And welcome to the Unum Therapeutics 2018 Q2 earnings conference call. [Operator instructions] Following management’s prepared…

EARNING UPDATE $SGEN Seattle Genetics, Inc. for quarter ending q_Jun18 – Revenue grew, Margins expanded

[s2If !current_user_can(access_s2member_level0)]Please login to read the earning update on SGEN [lwa][/s2If][s2If current_user_can(access_s2member_level0)]Seattle Genetics, Inc. reported earnings (EPS) of 0.47 per share for the quarter ending q_Jun18. This is vis-vis -0.73 per share for the previous quarter ending q_Mar18, a growth of 164.4 %. Compared to last year same quarter (q_Jun17),…

$SGEN 2018-07-29 : Transcripts- Edited Transcript of SGEN earnings conference call

[s2If !current_user_can(access_s2member_level0)] Please login to read the transcript. [lwa] [/s2If][s2If current_user_can(access_s2member_level0)]”

Q2 2018 Seattle Genetics Inc Earnings Call

Bothell Jul 30, 2018 (Thomson StreetEvents) — Edited Transcript of Seattle Genetics Inc earnings conference call or presentation Thursday, July 26, 2018 at 8:30:00pm GMT

TEXT version of Transcript

======…

$SGEN 2018-07-29 : Transcripts- SGEN Edited Transcript of SGEN earnings conference call

[s2If !current_user_can(access_s2member_level0)] Please login to read the transcript. [lwa] [/s2If][s2If current_user_can(access_s2member_level0)]”

Q2 2018 Seattle Genetics Inc Earnings Call

Bothell Jul 30, 2018 (Thomson StreetEvents) — Edited Transcript of Seattle Genetics Inc earnings conference call or presentation Thursday, July 26, 2018 at 8:30:00pm GMT

TEXT version of Transcript

======…